A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-5233 (Electronic) Linking ISSN: 09405429 NLM ISO Abbreviation: Acta Diabetol Subsets: MEDLINE
    • Publication Information:
      Publication: Berlin : Springer Verlag
      Original Publication: Berlin : Springer International, c1991-
    • Subject Terms:
    • References:
      Murphy HR, Howgate C, O’Keefe J et al (2021) Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(20)30406-X. (PMID: 10.1016/S2213-8587(20)30406-X)
      Brown E, Heerspink HJL, Cuthbertson DJ et al (2021) SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications. Lancet. https://doi.org/10.1016/S0140-6736(21)00536-5. (PMID: 10.1016/S0140-6736(21)00536-5)
      Trulicity US (2020) Prescribing Information. Eli Lilly and Company; http://pi.lilly.com/us/trulicity-uspi.pdf [Google Scholar].
      Lapolla A, Dalfrà MG, Fedele D (2008) Pregnancy complicated by type 2 diabetes: an emerging problem. Diabetes Res Clin Pract. https://doi.org/10.1016/j.diabres.2007.11.009. (PMID: 10.1016/j.diabres.2007.11.009)
      Lapolla A, Dalfrà MG, Di Cianni G et al (2008) A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr Metab Cardiovasc Dis. https://doi.org/10.1016/j.numecd.2006.12.001. (PMID: 10.1016/j.numecd.2006.12.001)
    • Contributed Indexing:
      Keywords: Diabetes type 2; Fetal outcomes; GLP-1; Pregnancy
    • Accession Number:
      WTT295HSY5 (dulaglutide)
      62340-29-8 (Glucagon-Like Peptides)
      0 (Hypoglycemic Agents)
      0 (Immunoglobulin Fc Fragments)
      0 (Recombinant Fusion Proteins)
      0 (Glucagon-Like Peptide-1 Receptor)
      0 (Blood Glucose)
    • Publication Date:
      Date Created: 20220922 Date Completed: 20230106 Latest Revision: 20230127
    • Publication Date:
      20240628
    • Accession Number:
      10.1007/s00592-022-01954-4
    • Accession Number:
      36136154